Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion’s technology could transform the imaging industry.
Prestige Biopharma and Imagion Biosystems Sign an MOU, Developing Early Pancreatic Cancer Diagnosis Platform
August 11, 2023
SINGAPORE, and San Diego, California – Prestige Biopharma, a biopharmaceutical company specializing in innovative antibody therapies, with a strong dedication to tackling pancreatic cancer, and Imagion